Location History:
- Mountain View, CA (US) (2010)
- Indianapolis, IN (US) (2021)
- Carmel, IN (US) (2014 - 2024)
Company Filing History:
6 out of 4,447 
3 out of 2,453 
Years Active: 2010-2024
Title: The Innovations of Chad Donald Paavola
Introduction
Chad Donald Paavola is a notable inventor based in Carmel, Indiana, known for his significant contributions to the field of insulin compositions. With a total of nine patents to his name, Paavola has made strides in developing rapid-acting insulin formulations that enhance the pharmacokinetic and pharmacodynamic properties of insulin.
Latest Patents
Among his latest patents, Paavola has developed compositions of human insulin or insulin analogs that include specific concentrations of citrate and chloride. These formulations may also incorporate sodium chloride, zinc, and optionally magnesium chloride and/or surfactants. The result is a composition that exhibits faster pharmacokinetic and/or pharmacodynamic action compared to existing commercial formulations of insulin analog products. Additionally, he has created another rapid-acting insulin composition that demonstrates quicker pharmacokinetic action than current rapid-onset insulin analog products.
Career Highlights
Throughout his career, Chad Paavola has worked with prominent organizations, including Eli Lilly and Company and the United States of America as represented by the Administrator of NASA. His work in these institutions has allowed him to contribute to advancements in medical technology and pharmaceuticals.
Collaborations
Paavola has collaborated with several professionals in his field, including Michael Patrick Akers and Chi Arch Nguyen. These partnerships have likely facilitated the development of his innovative insulin compositions.
Conclusion
Chad Donald Paavola's work in the field of rapid-acting insulin compositions showcases his dedication to improving diabetes management through innovative solutions. His contributions continue to impact the medical community positively.